English
Segment disclosures
Company overviewBLUM HOLDINGS, INC.
Each reported dimension combination stays separate. Revenue and operating income are shown as reported, with their dates and sources.
Revenue · Reported segment facts
Counts describe retained dimensioned rows only. Periods and members can change across reports, and this view does not infer missing values or expected segment totals.
Revenue From Contract With Customer · Product Concentration Risk · All Segments
Concentration Risk By Benchmark · Concentration Risk By Type · Statement Business Segments
Source dimensions
us-gaap:ConcentrationRiskByBenchmarkAxis=us-gaap:RevenueFromContractWithCustomerMember;us-gaap:ConcentrationRiskByTypeAxis=us-gaap:ProductConcentrationRiskMember;us-gaap:StatementBusinessSegmentsAxis=blmh:AllSegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2025-01-01 – 2025-09-30 | 10565000 | USD | 20251114 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 5718000 | USD | 20250813 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 9933000 | USD | 20251114 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 5569000 | USD | 20250813 | Open filing evidence |
Revenue From Contract With Customer · Product Concentration Risk · Cannabis Cultivation And Distributions
Concentration Risk By Benchmark · Concentration Risk By Type · Statement Business Segments
Source dimensions
us-gaap:ConcentrationRiskByBenchmarkAxis=us-gaap:RevenueFromContractWithCustomerMember;us-gaap:ConcentrationRiskByTypeAxis=us-gaap:ProductConcentrationRiskMember;us-gaap:StatementBusinessSegmentsAxis=blmh:CannabisCultivationAndDistributionsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2025-01-01 – 2025-09-30 | 237000 | USD | 20251114 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 167000 | USD | 20250813 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 140000 | USD | 20251114 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 59000 | USD | 20250813 | Open filing evidence |
Revenue From Contract With Customer · Product Concentration Risk · Cannabis Retail
Concentration Risk By Benchmark · Concentration Risk By Type · Statement Business Segments
Source dimensions
us-gaap:ConcentrationRiskByBenchmarkAxis=us-gaap:RevenueFromContractWithCustomerMember;us-gaap:ConcentrationRiskByTypeAxis=us-gaap:ProductConcentrationRiskMember;us-gaap:StatementBusinessSegmentsAxis=blmh:CannabisRetailMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2025-01-01 – 2025-09-30 | 10328000 | USD | 20251114 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 5551000 | USD | 20250813 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 9793000 | USD | 20251114 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 5510000 | USD | 20250813 | Open filing evidence |
Product Concentration Risk · Cannabis Cultivation And Distributions
Concentration Risk By Type · Statement Business Segments
Source dimensions
us-gaap:ConcentrationRiskByTypeAxis=us-gaap:ProductConcentrationRiskMember;us-gaap:StatementBusinessSegmentsAxis=blmh:CannabisCultivationAndDistributionsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2024-01-01 – 2024-09-30 | 140000 | USD | 20241112 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 400000 | USD | 20241112 | Open filing evidence |
Cannabis Cultivation And Distributions
Statement Business Segments
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=blmh:CannabisCultivationAndDistributionsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2025-07-01 – 2025-09-30 | 70000 | USD | 20251114 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 237000 | USD | 20251114 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 97000 | USD | 20250813 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 167000 | USD | 20250813 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 70000 | USD | 20250514 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 189000 | USD | 20250313 | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 81000 | USD | 20251114 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 140000 | USD | 20251114 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 39000 | USD | 20250813 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 59000 | USD | 20250813 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 20000 | USD | 20250514 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 316000 Restated | USD | 20250313 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | -178000 | USD | 20241112 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 400000 | USD | 20241112 | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 145000 | USD | 20240814 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 578000 | USD | 20240814 | Open filing evidence |
| 2023-01-01 – 2023-03-31 | 433000 | USD | 20240514 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 12078000 | USD | 20240415 | Open filing evidence |
Cannabis Retail
Statement Business Segments
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=blmh:CannabisRetailMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2025-07-01 – 2025-09-30 | 4777000 | USD | 20251114 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 10328000 | USD | 20251114 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 3381000 | USD | 20250813 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 5551000 | USD | 20250813 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 2170000 | USD | 20250514 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 12801000 | USD | 20250313 | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 4283000 | USD | 20251114 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 9793000 | USD | 20251114 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 3756000 | USD | 20250813 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 5510000 | USD | 20250813 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 1754000 Restated | USD | 20250514 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 7440000 Restated | USD | 20250313 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 1727000 | USD | 20241112 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 5295000 | USD | 20241112 | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 2122000 | USD | 20240814 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 3568000 | USD | 20240814 | Open filing evidence |
| 2023-01-01 – 2023-03-31 | 8184000 | USD | 20240514 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 39937000 | USD | 20240415 | Open filing evidence |
Cannabis Cultivation Distributions
Statement Business Segments
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=blum:CannabisCultivationDistributionsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2023-04-01 – 2023-06-30 | 382000 | USD | 20231010 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 1152000 | USD | 20231010 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 12078000 | USD | 20231010 | Open filing evidence |
| 2022-04-01 – 2022-06-30 | 4661000 | USD | 20231010 | Open filing evidence |
| 2022-01-01 – 2022-06-30 | 10997000 | USD | 20231010 | Open filing evidence |
| 2021-01-01 – 2021-12-31 | 17580000 | USD | 20231010 | Open filing evidence |
Cannabis Retail
Statement Business Segments
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=blum:CannabisRetailMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2023-04-01 – 2023-06-30 | 8415000 | USD | 20231010 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 16885000 | USD | 20231010 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 39937000 | USD | 20231010 | Open filing evidence |
| 2022-04-01 – 2022-06-30 | 11140000 | USD | 20231010 | Open filing evidence |
| 2022-01-01 – 2022-06-30 | 23653000 | USD | 20231010 | Open filing evidence |
| 2021-01-01 – 2021-12-31 | 24540000 | USD | 20231010 | Open filing evidence |
Corporate And Other
Statement Business Segments
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=us-gaap:CorporateAndOtherMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2025-07-01 – 2025-09-30 | 0 | USD | 20251114 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 0 | USD | 20251114 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 0 | USD | 20250813 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 0 | USD | 20250813 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 0 | USD | 20250514 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 0 | USD | 20250313 | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 0 | USD | 20251114 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 0 | USD | 20251114 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 0 | USD | 20250813 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 0 | USD | 20250813 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 0 | USD | 20250514 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 0 | USD | 20250313 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 0 | USD | 20241112 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 0 | USD | 20241112 | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 0 | USD | 20240814 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 0 | USD | 20240814 | Open filing evidence |
| 2023-01-01 – 2023-03-31 | 0 | USD | 20240514 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 0 | USD | 20240415 | Open filing evidence |